title: Comparison between segmentectomy and larger resection of stage IA non-small cell lung carcinoma.
abstract: OBJECTIVE
  Stage IA non small cell lung carcinoma (NSCLC) represents early cancer and is best treated by surgery. The frequency of recurrence and new primary cancer varies from one report to another while the role of sublobar resection is still debated.
  
  
  METHODS
  We retrospectively reviewed 121 consecutive patients with pathological stage IA after radical surgery.
  
  
  RESULTS
  In stage IA NSCLC 1-, 3-, 5-year survival rates were 89%, 76% and 66%. Nearly half of the deaths were unrelated to the original cancer. From statistical analysis we did not find any factor indicative of a better prognosis. We did not find any difference in survival between histologic types. Segmentectomy did not show a worse survival rate compared with larger resection.
  
  
  CONCLUSIONS
  Survival is neither influenced by the type of resection nor by the histologic types in stage IA. However, we noticed a high incidence of local recurrence, segmentectomy could be a viable choice in patients with cardiopulmonary impairment.
authors.affiliation: Department of Thoracic and Cardiovascular Surgery, University Hospital Le Scotte, Siena, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Campione
authors.forename: T
authors.initials: T
authors.lastname: Ligabue
authors.forename: L
authors.initials: L
authors.lastname: Luzzi
authors.forename: C
authors.initials: C
authors.lastname: Ghiribelli
authors.forename: L
authors.initials: L
authors.lastname: Voltolini
authors.forename: P
authors.initials: P
authors.lastname: Paladini
authors.forename: M
authors.initials: M
authors.lastname: Di Bisceglie
authors.forename: A
authors.initials: A
authors.lastname: D'Agata
authors.forename: G
authors.initials: G
authors.lastname: Gotti
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology / Q000601:surgery; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018196:Carcinoma, Adenosquamous / Q000401:mortality / Q000473:pathology / Q000601:surgery; D018287:Carcinoma, Large Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology / Q000601:surgery; D005260:Female; D017052:Hospital Mortality; D006785:Hospitals, University; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009367:Neoplasm Staging; D011013:Pneumonectomy / Q000009:adverse effects / Q000379:methods*; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome